Cargando…
Advanced T and Natural Killer Cell Therapy for Glioblastoma
Although immunotherapy has been broadly successful in the treatment of hematologic malignancies and a subset of solid tumors, its clinical outcomes for glioblastoma are still inadequate. The results could be due to neuroanatomical structures such as the blood-brain-barrier, antigenic heterogeneity,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Neurosurgical Society
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323271/ https://www.ncbi.nlm.nih.gov/pubmed/36588388 http://dx.doi.org/10.3340/jkns.2022.0267 |